Comparison of Over-the-Scope Clips to Standard Endoscopic Treatment as the Initial Treatment in Patients With Bleeding From a Nonvariceal Upper Gastrointestinal Cause

医学 上消化道出血 内窥镜检查 止血 外科 内镜治疗 剪辑 胃肠道出血 随机对照试验 输血 内科学
作者
James Y. Lau,Rui Li,Chenhuan Tan,Xiujing Sun,Hao-jun Song,Lan Li,Feng Ji,Bu-jiang Wang,Dongtao Shi,Wai K. Leung,Imogen Hartley,Alan Moss,Karina Yuanyuan Yu,Bing Yee Suen,Peng Li,Francis K.L. Chan
出处
期刊:Annals of Internal Medicine [American College of Physicians]
卷期号:176 (4): 455-462 被引量:27
标识
DOI:10.7326/m22-1783
摘要

Current endoscopic methods in the control of acute nonvariceal bleeding have a small but clinically significant failure rate. The role of over-the-scope clips (OTSCs) as the first treatment has not been defined.To compare OTSCs with standard endoscopic hemostatic treatments in the control of bleeding from nonvariceal upper gastrointestinal causes.A multicenter, randomized controlled trial. (ClinicalTrials.gov: NCT03216395).University teaching hospitals in Hong Kong, China, and Australia.190 adult patients with active bleeding or a nonbleeding visible vessel from a nonvariceal cause on upper gastrointestinal endoscopy.Standard hemostatic treatment (n = 97) or OTSC (n = 93).The primary outcome was 30-day probability of further bleeds. Other outcomes included failure to control bleeding after assigned endoscopic treatment, recurrent bleeding after initial hemostasis, further intervention, blood transfusion, and hospitalization.The 30-day probability of further bleeding in the standard treatment and OTSC groups was 14.6% (14 of 97) and 3.2% (3 of 93), respectively (risk difference, 11.4 percentage points [95% CI, 3.3 to 20.0 percentage points]; P = 0.006). Failure to control bleeding after assigned endoscopic treatment in the standard treatment and OTSC groups was 6 versus 1 (risk difference, 5.1 percentage points [CI, 0.7 to 11.8 percentage points]), respectively, and 30-day recurrent bleeding was 8 versus 2 (risk difference, 6.6 percentage points [CI, -0.3 to 14.4 percentage points]), respectively. The need for further interventions was 8 versus 2, respectively. Thirty-day mortality was 4 versus 2, respectively. In a post hoc analysis with a composite end point of failure to successfully apply assigned treatment and further bleeds, the event rate was 15 of 97 (15.6%) and 6 of 93 (6.5%) in the standard and OTSC groups, respectively (risk difference, 9.1 percentage points [CI, 0.004 to 18.3 percentage points]).Clinicians were not blinded to treatment and the option of crossover treatment.Over-the-scope clips, as an initial treatment, may be better than standard treatment in reducing the risk for further bleeding from nonvariceal upper gastrointestinal causes that are amenable to OTSC placement.General Research Fund to the University Grant Committee, Hong Kong SAR Government.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
BTim完成签到 ,获得积分10
2秒前
3秒前
明明就发布了新的文献求助10
4秒前
4秒前
4秒前
5秒前
Jackcaosky完成签到 ,获得积分10
5秒前
掉头发的小白完成签到,获得积分10
5秒前
5秒前
科研战神完成签到,获得积分10
6秒前
火星上云朵完成签到 ,获得积分10
6秒前
儒雅的斑马完成签到,获得积分10
7秒前
赘婿应助lifengxia采纳,获得10
7秒前
风格的好的完成签到,获得积分10
7秒前
量子星尘发布了新的文献求助50
9秒前
9秒前
科研战神发布了新的文献求助10
10秒前
lztong完成签到,获得积分10
10秒前
10秒前
在水一方应助甘特采纳,获得10
10秒前
11秒前
12秒前
KKUMee完成签到,获得积分10
13秒前
13秒前
17秒前
里予关注了科研通微信公众号
17秒前
木木林姐姐完成签到 ,获得积分10
18秒前
19秒前
tl完成签到,获得积分10
19秒前
max发布了新的文献求助10
20秒前
20秒前
WANGJD完成签到,获得积分10
21秒前
21秒前
22秒前
量子星尘发布了新的文献求助10
22秒前
丘比特应助闰土采纳,获得10
23秒前
星辰大海应助媛小媛啊采纳,获得10
23秒前
传奇3应助xiaoju采纳,获得10
24秒前
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Social Work Ethics Casebook: Cases and Commentary (revised 2nd ed.).. Frederic G. Reamer 1070
Alloy Phase Diagrams 1000
Introduction to Early Childhood Education 1000
2025-2031年中国兽用抗生素行业发展深度调研与未来趋势报告 1000
List of 1,091 Public Pension Profiles by Region 891
Historical Dictionary of British Intelligence (2014 / 2nd EDITION!) 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5424683
求助须知:如何正确求助?哪些是违规求助? 4539082
关于积分的说明 14165073
捐赠科研通 4456131
什么是DOI,文献DOI怎么找? 2444042
邀请新用户注册赠送积分活动 1435140
关于科研通互助平台的介绍 1412483